- RESEARCH HIGHLIGHT
Targeting viruses in their phase
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 20, 667 (2021)
doi: https://doi.org/10.1038/d41573-021-00129-0
This article originally appeared in Nat. Rev. Mol. Cell Biol. (https://doi.org/10.1038/s41580-021-00400-7)
References
Wang, S. et al. Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat. Cell Biol. https://doi.org/10.1038/s41556-021-00710-0 (2021)
Risso-Ballester, J. et al. A condensate-hardening drug blocks RSV replication in vivo. Nature https://doi.org/10.1038/s41586-021-03703-z (2021)